Pierre Socha

Principal

Pierre joined Amadeus Capital Partners in 2012 and leads early stage Health & Bio investments at Amadeus. He is on the boards of Inotec, Ori Biotech, Doctify, Congenica, PhoreMost and oversees our investment in Organox.

Pierre brings operational experience to these investments, having managed the growth of several life science businesses in Asia and Europe. During a decade at biotech company Avesthagen, he guided the group’s strategy and European activities, contributing to acquisitions, joint ventures and exits.

Pierre is French and holds an MSc in Environmental Economics (Hons.-SciencesEco) from Université de Provence, France and a BSc in Finance (Math Spe.-SciencesEco) from Université Louis Pasteur, France. He has attended executive programs at Harvard, MIT and Stanford.

Pierre speaks French and English.